Andy Chevigné and his team, RTI-5152-12 is postulated to boost the levels of opioid peptides that bind to classical opioid receptors while in the brain, resulting in heightened painkilling action. The LIH-RTI exploration groups established a collaboration arrangement and submitted a joint patent software in December 2020.Scientific American is a c